
|Articles|February 29, 2012
Dr. Robert Dubois On Promoting Comparative Results Vs. Methodology
Advertisement
Robert W. Dubois, MD, PhD, Chief Science Officer, National Pharmaceutical Council, discusses the different circumstances in the level of restrictions and evidence regarding comparative effectiveness research. In addition, Dr. Dubois asks whether the standards around safety differ from those around efficacy.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis
2
Discontinuation of ACA Subsidies Will Leave Many Uninsured: Ciara Zachary, PhD, MPH
3
BMI in CAR T: Overweight Status Predicts Worse MM Outcomes
4
ncRNAs Linked to CLL Outcomes, Meta-Analysis Finds
5













































